Text Box: OBSERVING OF 237 CASE MYCOPLASMA PNEUMONIA INFECTIONS TREATED WITH ERYTHROMYCIN AND AZITHROMYCIN
Wang Shuyi, Shao Ying, Zhang Lili
Dalian Municipal Central Hospital, Dalian, China

Objective: 237 cases mycoplasma pneumonia (MP) infections treated with Erythromycin and Azithromycin were analyzed to compare the effects of the two drugs.
Methods: Divide the 237cases into two groups, which are all mycoplasma pneumonia infections detected by MP culture or MP specific antibody and not treated with in this course, A group is 96 cases continuous 7 days intravenous dripping of Erythromycin 20-30 mg/kg.d, B group is 131 cases continuous 7 days intravenous dripping of Azithromycin 10 mg/kg.d., both of which were treated according to symptoms such as cough, asthma and fever, etc. 
Results: There is significant difference between two groups on the relieving time of children¡¯s symptoms such as cough, fever and other physical signs (p<0.01) and the relieving time of extrapulmonary signs (p<0.01). The recurrence rate of B group is significant lower than that of A group.
Conclusion: Intravenous dripping of Azithromycin is more effective with higher tissue concentration, longer effect time, fewer side effects, shorter treating course and less recurrence. 
1888